High Value Medical Assays

Roche is helping labs improve patient care with high medical value assays that provide critical, actionable insights to inform therapeutic decisions for treating cancer. Our high medical value assays and companion diagnostics solutions are ready to use and are fully automated to streamline workflow and ensure patient safety.

Identify more patients for the right drug at the right time

Roche offers the largest menu of ready-to-use IHC assays across disease states, including predictive assays with the greatest number of therapies on label. Our leading portfolio of companion diagnostics represents access to a broad range of cancer therapies.


Product	Indications	Health Canada Approved Therapies
VENTANA anti-ALK (D5F3 Rabbit monoclonal Primary Antibody	NSCLC	XALKORI ZYKADIA ALECENSA
VENTANA PD-L1 (SP142) Assay	NSCLC, Breast	TECENTRIQ
VENTANA PD-L1 (SP263) Assay	NSCLC	KEYTRUDA OPDIVO TECENTRIQ
VENTANA anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody	Breast, Gastric	HERCEPTIN KADCYLA PERJETA
VENTANA HER2 Dual ISH DNA Probe Cocktail	Breast, Gastric	HERCEPTIN

Analytical Assays


Product	Indications	Health Canada Approved Therapies
VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody	NSCLC
CINtec® p16 Histology	Cervical
CINtec® PLUS Cytology	Cervical
CONFIRM anti-Estrogen Receptor (ER) (SP1) Rabbit Monoclonal Primary Antibody	Breast
CONFIRM anti-Progesterone Receptor (PR) (1E2) Rabbit Monoclonal Primary Antibody	Breast
VENTANA MMR IHC Panel	Colorectal, Solid tumors
VENTANA pan-TRK (EPR17341) Assay	Solid tumors
VENTANA Anti-PRAME (EPR20330) Rabbit Monoclonal Antibody	Skin